Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 20538015)

1.

A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.

Widera M, Hillebrand F, Erkelenz S, Vasudevan AA, Münk C, Schaal H.

Retrovirology. 2014 Aug 29;11:72. doi: 10.1186/s12977-014-0072-1.

2.

Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB.

da Costa KS, Leal E, dos Santos AM, Lima e Lima AH, Alves CN, Lameira J.

PLoS One. 2014 Feb 26;9(2):e89116. doi: 10.1371/journal.pone.0089116. eCollection 2014.

3.

HIV accessory proteins versus host restriction factors.

Strebel K.

Curr Opin Virol. 2013 Dec;3(6):692-9. doi: 10.1016/j.coviro.2013.08.004. Epub 2013 Nov 15. Review.

4.

HIV relies on neddylation for ubiquitin ligase-mediated functions.

Nekorchuk MD, Sharifi HJ, Furuya AK, Jellinger R, de Noronha CM.

Retrovirology. 2013 Nov 18;10:138. doi: 10.1186/1742-4690-10-138.

5.

Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.

Lu Z, Bergeron JR, Atkinson RA, Schaller T, Veselkov DA, Oregioni A, Yang Y, Matthews SJ, Malim MH, Sanderson MR.

Open Biol. 2013 Nov 13;3(11):130100. doi: 10.1098/rsob.130100.

6.

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

Miller LK, Kobayashi Y, Chen CC, Russnak TA, Ron Y, Dougherty JP.

Retrovirology. 2013 Oct 24;10:120. doi: 10.1186/1742-4690-10-120.

7.

Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, Chevalier SA, Edwards D, Ruscetti F, Pise-Masison CA, Franchini G.

J Virol. 2014 Jan;88(1):393-402. doi: 10.1128/JVI.01788-13. Epub 2013 Oct 23.

8.

Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.

Kehl T, Tan J, Materniak M.

Viruses. 2013 Sep 13;5(9):2169-209. doi: 10.3390/v5092169. Review.

9.

The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.

Rathore A, Carpenter MA, Demir Ö, Ikeda T, Li M, Shaban NM, Law EK, Anokhin D, Brown WL, Amaro RE, Harris RS.

J Mol Biol. 2013 Nov 15;425(22):4442-54. doi: 10.1016/j.jmb.2013.07.040. Epub 2013 Aug 11.

10.

APOBEC3 inhibits DEAD-END function to regulate microRNA activity.

Ali S, Karki N, Bhattacharya C, Zhu R, MacDuff DA, Stenglein MD, Schumacher AJ, Demorest ZL, Harris RS, Matin A, Aggarwal S.

BMC Mol Biol. 2013 Jul 26;14:16. doi: 10.1186/1471-2199-14-16.

11.

The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.

Casey Klockow L, Sharifi HJ, Wen X, Flagg M, Furuya AK, Nekorchuk M, de Noronha CM.

Virology. 2013 Sep;444(1-2):191-202. doi: 10.1016/j.virol.2013.06.010. Epub 2013 Jul 9.

12.

Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses.

Bélanger K, Savoie M, Rosales Gerpe MC, Couture JF, Langlois MA.

Nucleic Acids Res. 2013 Aug;41(15):7438-52. doi: 10.1093/nar/gkt527. Epub 2013 Jun 12.

13.

APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study.

Hosseini I, Mac Gabhann F.

PLoS One. 2013 May 22;8(5):e63984. doi: 10.1371/journal.pone.0063984. Print 2013.

14.

Innovation spread: lessons from HIV.

Talbert-Slagle K, Berg D, Bradley EH.

Int J Qual Health Care. 2013 Sep;25(4):352-6. doi: 10.1093/intqhc/mzt038. Epub 2013 May 21.

15.

Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count.

Bizinoto MC, Yabe S, Leal É, Kishino H, Martins Lde O, de Lima ML, Morais ER, Diaz RS, Janini LM.

BMC Infect Dis. 2013 Apr 11;13:173. doi: 10.1186/1471-2334-13-173.

16.

APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.

Batisse J, Guerrero SX, Bernacchi S, Richert L, Godet J, Goldschmidt V, Mély Y, Marquet R, de Rocquigny H, Paillart JC.

J Virol. 2013 Jun;87(11):6492-506. doi: 10.1128/JVI.03494-12. Epub 2013 Apr 10.

17.

HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.

Takaori-Kondo A, Shindo K.

Front Microbiol. 2013 Feb 20;4:34. doi: 10.3389/fmicb.2013.00034. eCollection 2013.

18.

Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent.

Chan K, Sterling JF, Roberts SA, Bhagwat AS, Resnick MA, Gordenin DA.

PLoS Genet. 2012;8(12):e1003149. doi: 10.1371/journal.pgen.1003149. Epub 2012 Dec 13.

19.

An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Widera M, Erkelenz S, Hillebrand F, Krikoni A, Widera D, Kaisers W, Deenen R, Gombert M, Dellen R, Pfeiffer T, Kaltschmidt B, Münk C, Bosch V, Köhrer K, Schaal H.

J Virol. 2013 Mar;87(5):2707-20. doi: 10.1128/JVI.02755-12. Epub 2012 Dec 19.

20.

Evasion from NK cell-mediated immune responses by HIV-1.

Jost S, Altfeld M.

Microbes Infect. 2012 Sep;14(11):904-15. doi: 10.1016/j.micinf.2012.05.001. Epub 2012 May 21. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk